TABLE 3.
Percentage of Children Aged 3–17 Years Who Took Medication for ASD or Received Behavioral Treatment of ASD, Among Children Aged 3–17 Years Who Currently Have ASD and are Insured, United States, 2016
Medication for ASD (n = 323) | Behavioral Treatment of ASD (n = 686) | |||||
---|---|---|---|---|---|---|
Weighted % | Adjusted PRRa | 95% CI | Weighted % | Adjusted PRRa | 95% CI | |
Overall | 27.4 | — | — | 64.2 | — | — |
Sex | ||||||
Boys | 30.1 | 1.30 | 0.89–1.89 | 63.1 | 0.96 | 0.81–1.14 |
Girls | 17.4 | 1.00 | Referent | 68.4 | 1.00 | Referent |
Race and/or ethnicity | ||||||
Hispanic | 15.5 | 0.89 | 0.60–1.31 | 67.7 | 1.19 | 0.99–1.42 |
Non-Hispanic white | 30.1 | 1.00 | Referent | 62.5 | 1.00 | Referent |
Non-Hispanic African American | 41.2 | 1.12 | 0.79–1.58 | 67.2 | 1.10 | 0.89–1.34 |
Non-Hispanic other and/or multiracial | 21.1 | 0.90 | 0.58–1.39 | 59.9 | 0.92 | 0.71–1.19 |
Highest level of education by parent in household | ||||||
Less than high school | 55.5b | 1.74c | 1.17–2.59c | 49.5b | 0.64 | 0.39–1.05 |
High school, GED, vocational | 23.4 | 0.99 | 0.67–1.47 | 75.0 | 1.10 | 0.91–1.34 |
Some college and/or technical school | 23.8 | 0.88 | 0.61–1.26 | 63.5 | 1.00 | 0.83–1.20 |
College degree or higher | 24.3 | 1.00 | Referent | 63.6 | 1.00 | Referent |
Family structure | ||||||
2 parents, married | 24.5 | 1.00 | Referent | 64.8 | 1.00 | Referent |
2 parents, unmarried | 19.9b | 0.40c | 0.19–0.82c | 71.7 | 1.13 | 0.91–1.40 |
Single mother | 37.7 | 0.88 | 0.63–1.22 | 56.1 | 0.80 | 0.63–1.02 |
Other | 26.9 | 0.76 | 0.49–1.19 | 80.1 | 1.21 | 0.98–1.49 |
Household poverty | ||||||
<100% FPL | 27.6 | 1.03 | 0.57–1.84 | 68.7 | 1.08 | 0.81–1.43 |
100%–199% FPL | 34.3 | 1.33 | 0.77–2.27 | 58.6 | 0.98 | 0.71–1.35 |
200%–399% FPL | 22.5 | 1.09 | 0.73–1.63 | 64.9 | 1.00 | 0.82–1.24 |
≥400% FPL | 26.2 | 1.00 | Referent | 63.1 | 1.00 | Referent |
Insurance statusd | ||||||
Public only | 32.4 | 1.08 | 0.73–1.60 | 67.3 | 0.98 | 0.80–1.19 |
Private only | 22.4 | 1.00 | Referent | 64.4 | 1.00 | Referent |
Other | 24.6 | 1.03 | 0.71–1.49 | 50.2 | 0.80 | 0.62–1.03 |
Region | ||||||
Northeast | 26.3 | 1.41 | 0.89–2.24 | 67.5 | 1.11 | 0.88–1.41 |
Midwest | 34.4 | 1.95c | 1.26–3.00c | 61.0 | 1.03 | 0.81–1.31 |
South | 32.4 | 1.48 | 0.99–2.23 | 66.0 | 1.11 | 0.88–1.41 |
West | 12.4 | 1.00 | Referent | 61.9 | 1.00 | Referent |
Nativity | ||||||
US born | 27.2 | 0.73 | 0.42–1.27 | 64.0 | 0.77c | 0.63–0.93c |
Foreign born | 39.4b | 1.00 | Referent | 76.1b | 1.00 | Referent |
Years since first diagnosise | ||||||
0–2 | 18.1 | 1.00 | Referent | 68.9 | 1.00 | Referent |
3–6 | 22.5 | 1.12 | 0.76–1.65 | 65.1 | 0.98 | 0.81–1.18 |
≥7 | 42.9 | 1.66c | 1.19–2.32c | 62.8 | 0.92 | 0.77–1.12 |
Type of health care provider to give diagnosis | ||||||
Primary care provider | 28.7 | 1.00 | Referent | 55.7 | 1.00 | Referent |
Specialist | 24.4 | 0.82 | 0.61–1.11 | 65.7 | 1.15 | 0.89–1.49 |
Psychologist (school and nonschool) | 23.6 | 0.70 | 0.49–1.01 | 59.7 | 1.16 | 0.90–1.51 |
Psychiatrist | 35.2 | 1.03 | 0.74–1.44 | 69.7 | 1.18 | 0.89–1.57 |
Other or don’t know | 34.0 | 0.70 | 0.45–1.10 | 75.3 | 1.42c | 1.10–1.84c |
Co-occurring conditions | ||||||
ADD and/or ADHD (ref = no ADD and/or ADHD) | 47.5 | 3.30c | 2.14–5.07c | 62.8 | 0.84c | 0.70–0.99c |
Anxiety problems (ref = no anxiety problems) | 39.9 | 1.16 | 0.89–1.51 | 68.0 | 1.05 | 0.89–1.24 |
Developmental delay (ref = no developmental delay) | 32.1 | 1.30 | 0.98–1.73 | 68.2 | 1.08 | 0.93–1.26 |
Behavioral or conduct problems (ref = no behavioral or conduct problems) | 39.2 | 1.72c | 1.26–2.33c | 72.0 | 1.39c | 1.16–1.66c |
Currently taking medication for ASD | — | — | — | 75.3 | 1.31c | 1.13–1.52c |
Received behavioral treatment of ASD | 32.0 | 1.64c | 1.18–2.28c | — | — | — |
Data source: 2016 NSCH. GED, General Educational Development; ref, referent; —, not applicable.
Adjusted for all other demographic, sociodemographic, and birth characteristics shown.
Estimates are considered unreliable and should be used with caution. Data have a relative SE >30% or unweighted denominator n < 30.
Significant value.
Other insurance includes private, public, and unspecified.
The analyses included those with missing information on age at diagnosis (n = 95).